{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:33:40Z","timestamp":1791804820731,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31301142"],"award-info":[{"award-number":["31301142"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tianjin Natural Science Foundation of China","award":["12JCYBJC31600"],"award-info":[{"award-number":["12JCYBJC31600"]}]},{"name":"Tianjin Natural Science Foundation of China","award":["11JGYBJC14300"],"award-info":[{"award-number":["11JGYBJC14300"]}]},{"name":"International Science & Technology Cooperation Program of China","award":["2013DFA31160"],"award-info":[{"award-number":["2013DFA31160"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.ejmech.2015.12.050","type":"journal-article","created":{"date-parts":[[2016,2,6]],"date-time":"2016-02-06T21:15:55Z","timestamp":1454793355000},"page":"145-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["Synthesis and anti-cancer activity evaluation of 5-(2-carboxyethenyl)-isatin derivatives"],"prefix":"10.1016","volume":"112","author":[{"given":"Yu-Ou","family":"Teng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Ye","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Le","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Lin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Chuan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2015.12.050_bib1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ejmech.2015.09.021","article-title":"Isatin-pyrazole benzenesulfonamide hybrids potently inhibit tumor-associated carbonic anhydrase isoforms IX and XII","volume":"103","author":"Ibrahim","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.12.050_bib2","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s12272-011-0705-z","article-title":"Synthesis of mono, bis-2-(2-arylideneaminophenyl) indole azomethines as potential antimicrobial agents","volume":"34","author":"Rohini","year":"2011","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ejmech.2015.12.050_bib3","first-page":"49","article-title":"Anticonvulsant activity of Schiff bases of isatin derivatives","volume":"54","author":"Verma","year":"2004","journal-title":"Acta Pharm. (Zagreb, Croatia)"},{"key":"10.1016\/j.ejmech.2015.12.050_bib4","first-page":"209","article-title":"Synthesis, antibacterial and antifungal activities of N-mannich bases of 3-[N2-pyrimethaminylimino] isatin","volume":"64","author":"Pandeya","year":"2002","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2015.12.050_bib5","doi-asserted-by":"crossref","first-page":"779","DOI":"10.4103\/0250-474X.49121","article-title":"Design, synthesis and antiHIV activity of novel isatine-sulphonamides","volume":"70","author":"Selvam","year":"2008","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2015.12.050_bib6","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1248\/bpb.24.1149","article-title":"Synthesis and pharmacological activities of hydrazones, Schiff and Mannich bases of isatin derivatives","volume":"24","author":"Sridhar","year":"2001","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2015.12.050_bib7","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ejmech.2014.12.010","article-title":"Design, synthesis and QSAR study of certain isatin-pyridine hybrids as potential anti-proliferative agents","volume":"90","author":"Eldehna","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.12.050_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejmech.2015.09.025","article-title":"H2O-mediated isatin spiro-epoxide ring opening with NaCN: Synthesis of novel 3-tetrazolylmethyl-3-hydroxy-oxindole hybrids and their anticancer evaluation","volume":"104","author":"Sharma","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.12.050_bib9","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2174\/157018011795514159","article-title":"Synthesis, cytotoxic and phytotoxic effects of some new N4-aryl substituted isatin-3-thiosemicarbazones","volume":"8","author":"Pervez","year":"2011","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.ejmech.2015.12.050_bib10","first-page":"320","article-title":"5-(2-Oxo-3-indolinylidene)thiazolidine-2,4-dione-1,3-di-Mannich base derivatives: synthesis and evaluation for antileukemic activity","volume":"40","author":"Eshba","year":"1985","journal-title":"Die Pharm."},{"key":"10.1016\/j.ejmech.2015.12.050_bib11","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/jps.2600720330","article-title":"Potential anticonvulsants VI: condensation of isatins with cyclohexanone and other cyclic ketones","volume":"72","author":"Pajouhesh","year":"1983","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.ejmech.2015.12.050_bib12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1200\/JCO.2005.02.2574","article-title":"Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma","volume":"24","author":"Motzer","year":"2006","journal-title":"J.\u00a0Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2015.12.050_bib13","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1158\/1078-0432.CCR-05-2275","article-title":"Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylate","volume":"12","author":"Prenen","year":"2006","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.ejmech.2015.12.050_bib14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bmc.2010.11.028","article-title":"Inhibition of monoamine oxidase by selected C5- and C6-substituted isatin analogues","volume":"19","author":"Manley-King","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.12.050_bib15","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1021\/jm070506t","article-title":"Isatin sulfonamide analogs containing a Michael addition acceptor: a new class of caspase 3\/7 inhibitors","volume":"50","author":"Chu","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.12.050_bib16","doi-asserted-by":"crossref","first-page":"7637","DOI":"10.1021\/jm0506625","article-title":"N-benzylisatin sulfonamide analogues as potent caspase-3 inhibitors: synthesis, in\u00a0vitro activity, and molecular modeling studies","volume":"48","author":"Chu","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.12.050_bib17","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1021\/ci900144x","article-title":"Docking and 3D-QSAR studies on isatin sulfonamide analogues as caspase-3 inhibitors","volume":"49","author":"Wang","year":"2009","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2015.12.050_bib18","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1242\/dev.091744","article-title":"Cdks, cyclins and CKIs: roles beyond cell cycle regulation","volume":"140","author":"Lim","year":"2013","journal-title":"Dev. (Cambridge, England)"},{"key":"10.1016\/j.ejmech.2015.12.050_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2014.00001","article-title":"Apoptotic cell: linkage of inflammation and wound healing","volume":"5","author":"Wu","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2015.12.050_bib20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0300-483X(02)00464-X","article-title":"Role of mitochondria in toxic cell death","volume":"181\u2013182","author":"Robertson","year":"2002","journal-title":"Toxicology"},{"key":"10.1016\/j.ejmech.2015.12.050_bib21","doi-asserted-by":"crossref","first-page":"a008680","DOI":"10.1101\/cshperspect.a008680","article-title":"Caspase substrates and inhibitors","volume":"5","author":"Poreba","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ejmech.2015.12.050_bib22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3892\/or.2013.2815","article-title":"Induction of G2\/M phase cell cycle arrest\u00a0and apoptosis by ginsenoside Rf in human osteosarcoma MG63 cells through the mitochondrial pathway","volume":"31","author":"Shangguan","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejmech.2015.12.050_bib23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.bmcl.2013.12.001","article-title":"Design, synthesis and in\u00a0vitro cytotoxicity evaluation of 5-(2-carboxyethenyl)isatin derivatives as anticancer agents","volume":"24","author":"Han","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.12.050_bib24","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.bbrc.2014.07.053","article-title":"5-(2-carboxyethenyl) isatin derivative induces G(2)\/M cell cycle arrest and apoptosis in human leukemia K562 cells","volume":"450","author":"Zhou","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2015.12.050_bib25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1021\/jm060631p","article-title":"2-(4-Chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[H]quinoline-4-carboxylic acid (PSI-697): identification of a clinical candidate from the quinoline salicylic acid series of P-selectin antagonists","volume":"50","author":"Kaila","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.12.050_bib26","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1016\/j.bmcl.2012.02.011","article-title":"Iodine-catalyzed condensation of isatin with indoles: a facile synthesis of di(indolyl)indolin-2-ones and evaluation of their cytotoxicity","volume":"22","author":"Subba Reddy","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.12.050_bib27","doi-asserted-by":"crossref","first-page":"4932","DOI":"10.1021\/jm8002203","article-title":"Design and synthesis of a novel series of N-alkyl isatin acylhydrazone derivatives that act as selective cannabinoid receptor 2 agonists for the treatment of neuropathic pain","volume":"51","author":"Diaz","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.12.050_bib28","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.ejmech.2009.12.010","article-title":"QSAR study of isatin analogues as in\u00a0vitro anti-cancer agents","volume":"45","author":"Sabet","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.12.050_bib29","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1016\/j.bmc.2010.03.030","article-title":"Design of potential reverse transcriptase inhibitor containing Isatin nucleus using molecular modeling studies","volume":"18","author":"Pawar","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.12.050_bib30","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1021\/jm0100537","article-title":"Potent and selective nonpeptide inhibitors of caspases 3 and 7","volume":"44","author":"Lee","year":"2001","journal-title":"J.\u00a0Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523415304360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523415304360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T01:40:33Z","timestamp":1565401233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523415304360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":30,"alternative-id":["S0223523415304360"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2015.12.050","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and anti-cancer activity evaluation of 5-(2-carboxyethenyl)-isatin derivatives","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2015.12.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}